CRT-100.86 Bioresorbable Vascular Scaffolds As A Treatment Option For Left Main Lesions

Since BVS have the ability to completely resorb in 3-4 years, they have many potential advantages over metallic stents; however, due to the limitations of current BVS and the complexity of LM disease, there are limited data regarding the safety and efficacy of BVS as a treatment option for LM